Epirium was founded by Pam Taub, Alan Maisel, Francisco Villarreal, Jonathan Taub, Guillermo Ceballos, Pam Taub, M.D., FACC, Alan Maisel, M.D., Francisco Villarreal, M.D., Ph.D., Guillermo Ceballos, M.D. in 2008.

Who are Epirium's investors?

Epirium's investors include Bluebird Ventures, Broadview Ventures, Longitude Capital, Adams Street Partners, ARCH Venture Partners, Vertex Ventures HC.

Where is Epirium headquartered?

Epirium is headquartered in San Diego, US.

Epirium

San Diego, US · Founded 2008 · 6 known investors

Find your way into Epirium

Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.

Biotech Medical Devices

Founders & leadership

Pam TaubM.D., FACC, Founder

Alan MaiselM.D., Founder

Francisco VillarrealM.D., Ph.D., Founder

Jonathan TaubCo-founder and first Chief Executive Officer

Guillermo CeballosM.D., Founding Scientist

Pam Taub, M.D., FACCCo-founder

Alan Maisel, M.D.Co-founder

Francisco Villarreal, M.D., Ph.D.Co-founder

Guillermo Ceballos, M.D.Founding scientist

Russell J. CoxPresident and CEO

Alexander CasdininChief Executive Officer

Investors · 6

Bluebird VenturesPalo Altovia Jeffrey Bird · inferred

Broadview VenturesBoston

Longitude CapitalMenlo Park · $10M – $30M

Adams Street PartnersreportedChicago · $150M – $750M

ARCH Venture PartnersreportedChicago · $50K – $250M

Vertex Ventures HCreportedSingapore · $500K – $10M

In the news

Everest Medicines raises $200M; Epirium Bio targets $55M Series Bendpoints.news · Jul 2025

Epirium Bio raises $85 million - Longevity.Technology - Latest News, Opinions, Analysis and Researchlongevity.technology · Jan 2020

Epirium Bio Inc. Raises USD 85 Million in Series Astartupcityapac.com · Dec 2019

Epirium Raises $85 Million in Series A Financing to Advance Unique Scientific Platform Focused on Restoration of Tissue Bioenergetics and Function | Business Wirebusinesswire.com · Dec 2019

Epirium Raises $85 Million to Develop Treatments for Rare Neuromuscular Diseases - Global Genesglobalgenes.org · Dec 2019

Frequently asked questions

What does Epirium do?: Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
Who founded Epirium?: Epirium was founded by Pam Taub, Alan Maisel, Francisco Villarreal, Jonathan Taub, Guillermo Ceballos, Pam Taub, M.D., FACC, Alan Maisel, M.D., Francisco Villarreal, M.D., Ph.D., Guillermo Ceballos, M.D. in 2008.
Who are Epirium's investors?: Epirium's investors include Bluebird Ventures, Broadview Ventures, Longitude Capital, Adams Street Partners, ARCH Venture Partners, Vertex Ventures HC.
Where is Epirium headquartered?: Epirium is headquartered in San Diego, US.